Thursday, December 07, 2006

New clinical trial offers hope to diabetics!

Ninemsn - Hopes for a vaccine to guard against juvenile diabetes have been boosted with the launch of a ground-breaking clinical trial in Melbourne.

The trial will use insulin administered with a nasal spray to children and young adults who are genetically predisposed to developing Type 1 diabetes.

If successful, researchers believe it could offer thousands of children protection from the disease, and the opportunity to avoid a life of constant blood-sugar monitoring, insulin injections and a regimented diet.

Researchers from the University of Melbourne's Diabetes Vaccine Development Centre are seeking 13,000 people aged between four and 30 who have a blood relative with Type 1 diabetes - and a higher risk of developing the disease - to undergo screening for the trial.

From those, it is expected about two per cent will be eligible to take part in the trial.

Read more…


Post a Comment

Links to this post:

Create a Link

<< Home